On November 12, 2020, at 07:00 CET, Calliditas Therapeutics published its interim report for the third quarter 2020.
Calliditas Therapeutics AB
Kungsbron 1, C8
SE-111 22 Stockholm
Company number: 556659-9766
© Calliditas Therapeutics AB 2020